A Study to Test How Avenciguat (BI 685509) is Taken up in the Body of People With and Without Liver Problems

Clinical trial NCT06272058 · TERMINATED

Trial details

NCT number: NCT06272058
Sponsor: Boehringer Ingelheim
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Liver Diseases

Start date: 2024-05-03
Primary completion: 2024-07-02
Enrollment: 4

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.